Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.24	23.37	20.46
Graham Fair Price	9.65	120.04	109.48
PEG	-43.93	0.36	-0.65
Price/Book	1.87	0.73	0.72
Price/Cash Flow	735.96	213.89	-25.59
Prices/Earnings	-10.35	6.05	6.75
Price/Sales	22.97	1.85	1.50
Price/FCF	735.96	213.89	-25.59
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.05	0.18	0.18
Operating Margin	6.95	0.11	0.10
ROA	21.49	0.01	< 0.005
ROE	0.03	0.03	13.62
ROIC	0.02	0.02	-13.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	-0.08	-23.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.06	-0.09	45.64
EPS QOQ	-0.10	0.17	59.89
FCF QOQ	-1.77	1.13	-36.29
Revenue QOQ	0.12	-0.15	26.10
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	60.81	78.31	28.78
Days Sales Outstanding (DSO)	88.39	103.45	17.04
Inventory Turnover	1.48	1.15	-22.35
Debt/Capitalization	0.49	0.51	2.80
Quick Ratio	0.73	0.74	1.06
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	141.37	145.42	2.86
Cash	33.86	33.29	-1.69
Capex	-6.53	-3.81	41.67
Free Cash Flow	-3.98	0.50	-87.47
Revenue	67.80	57.77	-14.79
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.09	1.13	3.73
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.81	12.55	16.11
Naive Interpretation	Member

06 - Financial Health · Bad

Rating